PT-141 (5mg)

Description

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. It is studied in preclinical research for its selective interactions with MC3R and MC4R melanocortin receptors.

Research indicates that PT-141 activates central melanocortin signaling pathways through hypothalamic MC4R activation, distinct from peripheral vascular mechanisms. It serves as a model compound for investigating melanocortin receptor selectivity, central nervous system signaling, and receptor-mediated behavioral pathways.

Specifications:
CAS Number: 189691-06-3
Molecular Formula: C50H68N14O10
Molecular Weight: 1025.17 g/mol
Purity: ≥99% (HPLC Verified)
Physical Form: Lyophilized Powder
Storage: Store at -20°C, protected from light

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.